Gene · 1909
Papers4,314
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 4,314
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Construction of the circRNA-miRNA-mRNA Regulatory Network of an Abdominal Aortic Aneurysm to Explore Its Potential Pathogenesis. | Dis Markers | 2021 | 34777635 | PubTator, text mining | PubMed |
| Synthesis and polymerase bypass studies of DNA-peptide and DNA-protein conjugates. | Methods Enzymol | 2021 | 34776221 | PubTator, text mining | PubMed |
| RNA-seq driven expression and enrichment analysis to investigate CVD genes with associated phenotypes among high-risk heart failure patients. | Hum Genomics | 2021 | 34774109 | PubTator, text mining | PubMed |
| Lysophosphatidic Acid Receptor 6 (LPAR6) Is a Potential Biomarker Associated with Lung Adenocarcinoma. | Int J Environ Res Public Health | 2021 | 34769557 | PubTator, text mining | PubMed |
| Autoantibodies from Patients with Scleroderma Renal Crisis Promote PAR-1 Receptor Activation and IL-6 Production in Endothelial Cells. | Int J Mol Sci | 2021 | 34769227 | PubTator, text mining | PubMed |
| Classification and Functional Analysis between Cancer and Normal Tissues Using Explainable Pathway Deep Learning through RNA-Sequencing Gene Expression. | Int J Mol Sci | 2021 | 34768960 | PubTator, text mining | PubMed |
| The emerging role of neutrophils in autoimmune-associated disorders: effector, predictor, and therapeutic targets. | MedComm (2020) | 2021 | 34766153 | PubTator, text mining | PubMed |
| An update on the CHDGKB for the systematic understanding of risk factors associated with non-syndromic congenital heart disease. | Comput Struct Biotechnol J | 2021 | 34765091 | PubTator, text mining | PubMed |
| Sex and gender in pulmonary arterial hypertension. | Eur Respir Rev | 2021 | 34750113 | PubTator, text mining | PubMed |
| Evaluation of Placentation and the Role of the Aryl Hydrocarbon Receptor Pathway in a Rat Model of Dioxin Exposure. | Environ Health Perspect | 2021 | 34747641 | PubTator, text mining | PubMed |
| Coronary Large Conductance Ca2+-Activated K+ Channel Dysfunction in Diabetes Mellitus. | Front Physiol | 2021 | 34744789 | PubTator, text mining | PubMed |
| Co-existing of craniofacial fibrous dysplasia and cerebrovascular diseases: a series of 22 cases and review of the literature. | Orphanet J Rare Dis | 2021 | 34736485 | PubTator, text mining | PubMed |
| Interleukin-6: Important Mediator of Vasospasm Following Subarachnoid Hemorrhage. | Curr Neurovasc Res | 2021 | 34736380 | PubTator, text mining | PubMed |
| Fragment-based design of selective GPCR ligands guided by free energy simulations. | Chem Commun (Camb) | 2021 | 34734588 | PubTator, text mining | PubMed |
| Comparison of critical biomarkers in 2 erectile dysfunction models based on GEO and NOS-cGMP-PDE5 pathway. | Medicine (Baltimore) | 2021 | 34731136 | PubTator, text mining | PubMed |
| Microinjection of pruritogens in NGF-sensitized human skin. | Sci Rep | 2021 | 34728705 | PubTator, text mining | PubMed |
| New Prognostic Biomarkers and Drug Targets for Skin Cutaneous Melanoma via Comprehensive Bioinformatic Analysis and Validation. | Front Oncol | 2021 | 34722301 | PubTator, text mining | PubMed |
| The Potential Use of Cannabis in Tissue Fibrosis. | Front Cell Dev Biol | 2021 | 34708034 | PubTator, text mining | PubMed |
| mTORC2 Activation Mediated by Mesenchymal Stem Cell-Secreted Hepatocyte Growth Factors for the Recovery of Lipopolysaccharide-Induced Vascular Endothelial Barrier. | Stem Cells Int | 2021 | 34707661 | PubTator, text mining | PubMed |
| Recognizing the salivary panomics for the clinical application in oral potentially malignant disorders. | J Oral Maxillofac Pathol | 2021 | 34703130 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1909/papers?page=49